Articles

P.33 Myeloma cast nephropathy leading to early kidney allograft dysfunction: a case report

BJH - volume 11, issue Abstract Book BHS, february 2020

G. Verstraete MD, I. Dufour , J. Raedemaeker , F. Andreozzi , L. Bamps , S. Chabert , A. Sogorb , N. Kanaan , M. De Meyer , A. Buemi , S. Aydin , M.C. Vekemans MD

Read more

P.27 IgM related AL amyloidosis: about 2 cases

BJH - volume 11, issue Abstract Book BHS, february 2020

J. Raedemaeker , F. Andreozzi , I. Dufour , L. Bamps , G. Verstraete MD, S. Chabert , S. Bailly MD, D. Maisin , J-P. Defour PhD, A. Camboni MD, PhD, dr. A-C. Pouleur , B. Gerber , F. Lecouvet , M.C. Vekemans MD

Read more

P.25 Ibrutinib-induced acrocyanosis

BJH - volume 11, issue Abstract Book BHS, february 2020

I. Dufour , G. Verstraete MD, J. Raedemaeker , F. Andreozzi , L. Bamps , S. Chabert , A. Sogorb , S. Bailly MD, E. Van den Neste MD, PhD, X. Theunssens , F. Tamirou , D. Tennstedt , A. Camboni MD, PhD, M.C. Vekemans MD

Read more

P.22 AL amyloidosis revealed by polyarthritis

BJH - volume 11, issue Abstract Book BHS, february 2020

K. Bennis , T. Schubert , F. Jamar , D. Maisin , A. Camboni MD, PhD, S. Aydin , F. Lecouvet , M.C. Vekemans MD

Read more

P.18 Daratumumab therapy in patients with immunoglobulin light chain amyloidosis, a single center experience

BJH - volume 11, issue Abstract Book BHS, february 2020

F. Andreozzi , I. Dufour , A. Sogorb , S. Chabert , G. Verstraete MD, J. Raedemaeker , L. Bamps , S. Bailly MD, F. Jamar , F. Lecouvet , A. Camboni MD, PhD, J-P. Defour PhD, dr. A-C. Pouleur , J. Morelle MD, PhD, M.C. Vekemans MD

Read more

Highlights in myelodysplastic syndromes

BJH - volume 10, issue 1, february 2019

M.C. Vekemans MD

Myelodysplastic syndromes (MDS) are a heterogeneous group of clonal hematopoietic malignancies characterized by peripheral blood cytopenias resulting from ineffective hematopoiesis. MDS is associated with a risk for progression to acute myeloid leukemia (AML). Progress in the field of this disease aims at decreasing the transfusion burden, delaying progression to AML, improving the quality-of-life (QoL) of patients and extending the survival. Here, we report some recent advances presented at the 60th Annual Meeting of the American Society of Hematology (ASH).

(BELG J HEMATOL 2019;10(1):24–30)

Read more

PP06 Hereditary predisposition syndromes to malignant hemopathies (HPSMH)

BJH - 2018, issue Abstract Book BHS, february 2018

S. Dupriez , A. Ferrant , M.C. Vekemans MD, B. Brichard MD, PhD, L. Michaux MD, PhD, T. Connerotte MD, E. Van den Neste MD, PhD, C. Vermylen , L. Knoops MD, PhD, C. Graux MD, PhD, F. Duhoux MD, PhD, C. Lambert MD, PhD, X. Poiré MD, PhD, H.A. Poirel MD, PhD

Read more